Article Details
Retrieved on: 2025-04-05 09:10:38
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article explores the impact of artificial intelligence on biopharmaceutical research and patent law, highlighting issues around AI's role in inventorship. Despite AI's contributions, U.S. patent law, guided by the Thaler decision and USPTO's 2024 guidance, mandates human inventorship, complicating patentability in biopharma. Tags indicate legal frameworks and entities involved in AI-related patentability discussions.
Article found on: www.jdsupra.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here